{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:18:19Z","timestamp":1787509099679,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001792","name":"James Cook University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.yexcr.2017.08.014","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:01:26Z","timestamp":1502323286000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells"],"prefix":"10.1016","volume":"359","author":[{"given":"Ali","family":"Razaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Villacr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Mashkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2017.08.014_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jlb.58.4.373","article-title":"Role of interferon-y in immune cell regulation","volume":"58","author":"Young","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jbiotec.2016.10.022","article-title":"Review of the recombinant human interferon gamma as an immunotherapeutic: impacts of production platforms and glycosylation","volume":"240","author":"Razaghi","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jir.1993.13.267","article-title":"Effect of carbohydrates on the pharmacokinetics of human interferon-gamma","volume":"13","author":"Sareneva","year":"1993","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.yexcr.2017.08.014_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj3080009","article-title":"N-glycosylation of human interferon-y: glycans at Asn-25 are critical for protease resistance","volume":"308","author":"Sareneva","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2017.08.014_bib5","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/jps.22473","article-title":"Prolonged circulation half-life of interferon gamma activity by gene delivery of interferon gamma-serum albumin fusion protein in mice","volume":"100","author":"Miyakawa","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.yexcr.2017.08.014_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biologicals.2016.09.015","article-title":"Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?","volume":"45","author":"Razaghi","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.yexcr.2017.08.014_bib7","first-page":"43","article-title":"Increased expression and secretion of recombinant hIFN\u03b3 through amino acid starvation-induced selective pressure on the adjacent HIS4 gene in Pichia pastoris","volume":"62","author":"Razaghi","year":"2015","journal-title":"Eur. Pharm. J."},{"key":"10.1016\/j.yexcr.2017.08.014_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5661\/bger-28-147","article-title":"Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation","volume":"28","author":"Ghaderi","year":"2012","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.yexcr.2017.08.014_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/11530550-000000000-00000","article-title":"Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy","volume":"24","author":"Sola","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.yexcr.2017.08.014_bib10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1054\/bjoc.1999.1053","article-title":"Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial","volume":"82","author":"Windbichler","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.08.014_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2008.01.005","volume":"109","author":"Alberts","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.ejca.2005.03.022","article-title":"Involvement of both intrinsic and extrinsic pathways in IFN-gamma-induced apoptosis that are enhanced with cisplatin","volume":"41","author":"Barton","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.08.014_bib14","first-page":"2487","article-title":"IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro","volume":"9","author":"Wall","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2017.08.014_bib15","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjc.6690491","article-title":"Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA","volume":"80","author":"Burke","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2017.08.014_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.it.2010.05.005","article-title":"FADD: a regulator of life and death","volume":"31","author":"Tourneur","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1535-7163.MCT-11-0362","article-title":"A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-kappaB","volume":"10","author":"Schinske","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexcr.2017.08.014_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4137\/BMI.S16553","article-title":"Increased expression of phosphorylated FADD in anaplastic large cell and other T-Cell lymphomas","volume":"9","author":"Patel","year":"2014","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.yexcr.2017.08.014_bib19","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/eji.200636541","article-title":"IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions","volume":"37","author":"Boselli","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib20","first-page":"125","article-title":"Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions","volume":"347","author":"Royle","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tig.2015.11.003","article-title":"Understanding the genetic mechanisms of cancer drug resistance using genomic approaches","volume":"32","author":"Hu","year":"2016","journal-title":"Trends Genet."},{"key":"10.1016\/j.yexcr.2017.08.014_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","article-title":"Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy","volume":"2","author":"Putt","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib23","doi-asserted-by":"crossref","first-page":"20003","DOI":"10.1074\/jbc.272.32.20003","article-title":"Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor 1 and overexpression of Bcl-2","volume":"272","author":"Saeki","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.32604\/biocell.2013.37.001","article-title":"High passage numbers induce resistance to apoptosis in C2C12 muscle cells","volume":"37","author":"Pronsato","year":"2013","journal-title":"Biocell: Off. J. Soc. Latinoam. De. Microsc. Electron. \u2026 et al."},{"key":"10.1016\/j.yexcr.2017.08.014_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2017.08.014_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2011.09.031","article-title":"Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1)","volume":"314","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2017.08.014_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7150\/ijbs.5763","article-title":"Overexpression of DOC-1R inhibits cell cycle G1\/S transition by repressing CDK2 expression and activation","volume":"9","author":"Liu","year":"2013","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2017.08.014_bib28","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrd1695","article-title":"Protein drug stability: a formulation challenge","volume":"4","author":"Frokjaer","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexcr.2017.08.014_bib29","doi-asserted-by":"crossref","first-page":"16677","DOI":"10.1073\/pnas.0808597105","article-title":"FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells","volume":"105","author":"Bell","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2017.08.014_bib30","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/MCB.05445-11","article-title":"NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis","volume":"31","author":"Thapa","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib31","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.onc.1204199","article-title":"Control of cell cycle progression in human mesothelioma cells treated with gamma interferon","volume":"20","author":"Vivo","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2017.08.014_bib32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/oxfordjournals.jbchem.a021639","article-title":"Analysis of IFN-\u03b3-induced cell cycle arrest and cell death in hepatocytes","volume":"121","author":"Kano","year":"1997","journal-title":"J. Biochem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib33","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1021\/bi9703655","article-title":"Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135","volume":"36","author":"Huang","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.yexcr.2017.08.014_bib34","first-page":"2832","article-title":"IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression","volume":"58","author":"Xu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2017.08.014_bib35","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2353\/ajpath.2006.050473","article-title":"Interferon-gamma induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism","volume":"168","author":"Rosner","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib36","first-page":"2199","article-title":"Interferon-\u03b3 induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells","volume":"40","author":"Jean","year":"1999","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yexcr.2017.08.014_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1470-8744.1995.tb00327.x","article-title":"The macroheterogeneity of recombinant human interferon\u2010gamma produced by Chinese\u2010hamster ovary cells is affected by the protein and lipid content of the culture medium","volume":"21","author":"Pm","year":"1995","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00762395","article-title":"Effect of lipid supplements on the production and glycosylation of recombinant interferon-gamma expressed in CHO cells","volume":"15","author":"Jenkins","year":"1994","journal-title":"Cytotechnology"},{"key":"10.1016\/j.yexcr.2017.08.014_bib39","first-page":"64771","article-title":"N-glycosylation of recombinant human interferon-y produced in different animal expression systems","volume":"13","author":"James","year":"1995","journal-title":"Biotechnology"},{"key":"10.1016\/j.yexcr.2017.08.014_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/gyno.2001.6242","article-title":"Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines","volume":"82","author":"Rieder","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jcb.10142","article-title":"Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells","volume":"85","author":"Kim","year":"2002","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib42","doi-asserted-by":"crossref","first-page":"14746","DOI":"10.1039\/c2jm31972a","article-title":"The apoptosis of OVCAR-3 induced by TNF-\u03b1 plus IFN-\u03b3 co-immobilized polylactic acid copolymers","volume":"22","author":"Guan","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.molcel.2005.06.024","article-title":"Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities","volume":"19","author":"Alappat","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2017.08.014_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5483\/BMBRep.2012.45.9.186","article-title":"The roles of FADD in extrinsic apoptosis and necroptosis","volume":"45","author":"Lee","year":"2012","journal-title":"BMB Rep."},{"issue":"362","key":"10.1016\/j.yexcr.2017.08.014_bib45","first-page":"e312","article-title":"Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells","volume":"205","author":"Li","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.yexcr.2017.08.014_bib46","doi-asserted-by":"crossref","first-page":"20722","DOI":"10.1074\/jbc.M413934200","article-title":"Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death","volume":"280","author":"Pyo","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.08.014_bib47","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1111\/j.1432-1033.2004.04362.x","article-title":"IFN-gamma enhances TRAIL-induced apoptosis through IRF-1","volume":"271","author":"Park","year":"2004","journal-title":"Eur. J. Biochem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717304251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717304251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:21:50Z","timestamp":1757996510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717304251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0014482717304251"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.08.014","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}